Industry News · Live

What's moving the medical supply market.

Curated from medtech publications. Product launches, FDA clearances, M&A, technology shifts — rewritten as short briefs, linked back to the source. Filter by theme below.

Live

Stories

Sources

Updated

0hours ago

Filter:All Technology New products Regulation Market

Feed

§001TechnologyMay 21, 2026

InterSystems Automates Bi-Directional Data Exchange between Epic Payer Platform and Health Plan Workflows

InterSystems announced automation of bi-directional data exchange between Epic's payer platform and health plan workflows. The integration streamlines data flow between payer systems and Epic's platform, reducing manual data handling and improving interoperability between health plan operations and Epic infrastructure. The move addresses connectivity gaps in the payer-provider IT landscape.

Source · Healthcare IT NewsRead brief

§002MarketApril 24, 2026

Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy

Telehealth clinic Hone Health partnered with imaging vendor BodySpec to offer DEXA body composition scans to GLP-1 patients. The collaboration aims to help providers differentiate fat loss from muscle loss during treatment, enabling more detailed assessment of drug efficacy beyond weight metrics alone. The partnership represents a vendor strategy move to integrate diagnostic imaging into remote weight-management workflows.

Source · MedCity NewsRead brief

§003TechnologyApril 24, 2026

AI may be approaching a new phase in healthcare, on two fronts

Physicians are adopting agentic AI tools like Claude Code to develop custom clinical applications, marking a shift toward clinician-led software development within health systems. While the approach promises to accelerate app creation, industry experts caution that widespread adoption requires new security audits and professional engineering oversight to address AI-generated vulnerabilities and protect patient data.

Source · Healthcare IT NewsRead brief

§004TechnologyApril 24, 2026

Interoperability governance gaps put pressure on nationwide exchange networks

Nationwide health information exchange networks are facing pressure to expand responsibilities beyond their original scope as interoperability demands grow, creating questions about whether existing governance structures can adapt. The gaps in governance frameworks are straining networks' ability to support modern data-sharing requirements across healthcare systems.

Source · Mobi Health NewsRead brief

§005MarketApril 24, 2026

Courier Health scores $50M to scale CRM technology

Courier Health, a health tech platform serving life sciences manufacturers, closed a $50 million Series B funding round led by Oak HC/FT, with participation from Norwest and Work-Bench. The New York-based company provides CRM technology to help manufacturers manage customer relationships and sales operations.

Source · Mobi Health NewsRead brief

§006TechnologyApril 24, 2026

New Zealand Telehealth Services to pilot AI support for helplines

Whakarongorau Aotearoa, New Zealand's telehealth services provider, will pilot a Microsoft Azure AI-powered service in May to assist callers during wait times before connecting with healthcare staff. The deployment represents a vendor adoption of cloud-based AI infrastructure to augment helpline operations and improve caller experience in a telehealth setting.

Source · Healthcare IT NewsRead brief

§007New productsApril 24, 2026

Imricor begins US commercial sales of NorthStar mapping system

Imricor Medical Systems has launched commercial sales of its NorthStar Mapping System in the US market. The system is designed for cardiac electrophysiology procedures, enabling real-time mapping and navigation during ablation and other interventional cardiac treatments. The commercial rollout follows regulatory clearance and positions Imricor to compete in the cardiac mapping and navigation device segment.

Source · Medical Device NetworkRead brief

§008RegulationApril 24, 2026

FDA and CMS outline new Medicare coverage pathway for medical device access

The FDA and CMS announced a new pathway designed to accelerate Medicare coverage decisions for medical devices following FDA approval. The initiative aims to streamline the process between regulatory clearance and reimbursement eligibility, reducing the time gap that typically delays device access to Medicare beneficiaries.

Source · Medical Device NetworkRead brief

§009TechnologyApril 24, 2026

OpenAI launches ChatGPT for Clinicians

OpenAI launched ChatGPT for Clinicians, a large-language-model tool designed for individual healthcare providers to assist with medical research, documentation, and sourced answers. The company positioned it for clinicians at facilities without centralized AI systems, with conversations excluded from model training. The offering represents an entry point for GPT-based AI into point-of-care workflows.

Source · Mobi Health NewsRead brief

§010MarketApril 24, 2026

Top Silicon Valley VCs Are Backing a New Health Tech Residency Program

The AI Health Fund launched Treehub, a residency program for early-stage healthcare AI startups, backed by prominent venture investors including Tim Draper and Anne Wojcicki. The program targets companies at pre-formation stages, signaling continued capital flow into the health tech vendor ecosystem.

Source · MedCity NewsRead brief

§011RegulationApril 23, 2026

J&J secures CE mark for ETHICON 4000 Stapler

Johnson & Johnson obtained CE mark approval for the ETHICON 4000 Stapler, a surgical stapling device designed to maintain staple line integrity across variable tissue thicknesses. The clearance enables commercial distribution in European markets.

Source · Medical Device NetworkRead brief

§012MarketApril 23, 2026

Boston Scientific reports steady Q1 2026 performance yet tempers FY26 outlook

Boston Scientific reported 11.2% year-over-year growth in Q1 2026 but reduced its full-year 2026 revenue guidance, trimming the top-end growth outlook by 2 percentage points. The adjustment signals caution amid what the company characterized as steady near-term performance across its device portfolio.

Source · Medical Device NetworkRead brief

§013TechnologyApril 23, 2026

How digitizers power next-generation SS-OCT systems

Advanced digitizers are enabling faster data acquisition in swept-source optical coherence tomography (SS-OCT) systems, supporting higher imaging speeds and improved sensitivity in real-time tissue visualization. SS-OCT's enhanced depth penetration and resolution compared to conventional OCT make digitizer performance critical to next-generation imaging system design.

Source · Medical Design & OutsourcingRead brief

§014RegulationApril 23, 2026

FDA grants clearance for Philips’ Rembra scanning platform

Philips received FDA 510(k) clearance for its Rembra platform of scanning systems, which includes the Rembra CT, Rembra RT, and Areta RT models. The clearance enables the vendor to market these imaging devices in the United States.

Source · Medical Device NetworkRead brief

§015RegulationApril 23, 2026

Trelleborg Costa Rica site earns ISO 13485 certification

Trelleborg Medical Solutions' manufacturing facility in Costa Rica has achieved ISO 13485:2016 certification, the international quality management standard for medical device design and manufacturing. The certification demonstrates the site's compliance with process controls and risk management requirements for medical device production.

Source · Medical Design & OutsourcingRead brief

§016RegulationApril 22, 2026

FDA warns device manufacturers of nitrosamine impurities that could cause cancer

The FDA Center for Devices and Radiological Health issued a warning to manufacturers of drug-device combination products alerting them to potential nitrosamine impurities, which are classified as probable carcinogens. The agency did not specify which device types or manufacturers are affected in the letter, but advised vigilance on contamination risks during manufacturing and sourcing of raw materials and components.

Source · Medical Design & OutsourcingRead brief

§017TechnologyApril 22, 2026

Wearable Noise Is Exploding — Trust Is the Filter

Wearable devices are generating unprecedented volumes of health data, but clinicians and payers face growing uncertainty about data reliability and clinical utility. The article examines the challenge of validating wearable outputs for clinical decision-making, reimbursement justification, and patient reassurance, highlighting a critical gap between device proliferation and evidence-based confidence in their outputs.

Source · MedCity NewsRead brief

§018RegulationApril 22, 2026

Xeltis gains EU CE mark on positive trial data for vascular access graft

Xeltis obtained CE mark approval in the EU for its aXess vascular access graft following positive pivotal trial results. The trial demonstrated 79% secondary patency and 1.3 patency-related reinterventions per patient year, meeting regulatory benchmarks for the hemodialysis access device.

Source · Medical Device NetworkRead brief

§019MarketApril 22, 2026

AcuityMD raises $80m for AI augmentation to medtech sales platform

AcuityMD secured $80 million in funding to expand its AI-powered sales platform serving medical device companies. The platform is designed to streamline commercial execution and sales operations for medtech vendors. The fresh capital will support integration of advanced AI capabilities into the existing system.

Source · Medical Device NetworkRead brief

§020RegulationApril 22, 2026

PSN Manufacturing earns ISO 9001 and 13485 certifications

PSN Manufacturing, a contract manufacturer of precision components and sub-assemblies for medical devices, has achieved ISO 9001:2015 and ISO 13485:2016 certifications. The dual certifications validate the company's quality management systems and regulatory compliance capabilities, positioning it to serve as a certified contract development and manufacturing organization (CDMO) for medical device suppliers.

Source · Medical Design & OutsourcingRead brief

§021New productsApril 21, 2026

Sentante’s breakthrough telesurgery system could redefine stroke care

Sentante, a robotics startup, announced a telesurgery system designed for endovascular stroke intervention. The platform aims to address a market gap, as endovascular medicine currently lacks a commercially dominant robotic surgical platform. CEO Edvardas Satkauskas highlighted unmet clinical needs in the specialty that the system targets.

Source · Medical Design & OutsourcingRead brief

§022MarketApril 21, 2026

CPC Biotech debuts unified bioprocess fluid portfolio

CPC Biotech has launched as a unified brand combining CPC's biopharma connectors with PSG Biotech's pumps, flow meters, and sensors into an integrated bioprocess fluid management portfolio. The company will debut publicly at INTERPHEX 2026 in April at the Javits Center in New York City. The consolidation brings together critical fluid handling components and expertise for biopharmaceutical manufacturing.

Source · Medical Design & OutsourcingRead brief

§023MarketApril 20, 2026

Henry Schein discloses exec pay for longtime CEO Stan Bergman’s final year

Henry Schein disclosed executive compensation for 2025, reporting pay increases for three of five top executives in what marks longtime CEO Stan Bergman's final year leading the Melville, New York-based medical products distributor. The company also raised median employee compensation year-over-year. Bergman has led Henry Schein, ranked among the world's largest medical device suppliers, for an extended tenure.

Source · Medical Design & OutsourcingRead brief

§024MarketApril 20, 2026

Eli Lilly Makes Another In Vivo Genetic Medicines Move With $3.2B Kelonia Acquisition

Eli Lilly acquired Kelonia Therapeutics for $3.2 billion to add an in vivo cell therapy program targeting multiple myeloma. The deal marks Lilly's third genetic medicines acquisition in as many years, following purchases of Verve and Orna Therapeutics, as the pharmaceutical giant diversifies its approach to in vivo genetic therapy across multiple platforms and disease targets.

Source · MedCity NewsRead brief

§025RegulationApril 20, 2026

Regulatory tips from a breakthrough noninvasive device startup

Compremium's Quantis CVP, a noninvasive central venous pressure measurement device, received FDA Breakthrough Device designation in January 2026 and was enrolled in the FDA's Total Product Life Cycle Advisory Program (TAP). The program provides regulatory guidance to accelerate development of high-priority medical devices. The designation and TAP enrollment support expedited patient access pathways for the device.

Source · Medical Design & OutsourcingRead brief

§026New productsApril 20, 2026

Freudenberg Medical launches ISO Class 5 cleanroom for biopharma

Freudenberg Medical announced CleanAssure, a new ISO Class 5 controlled cleanroom facility for processing sterile single-use assemblies in biopharma manufacturing. The service combines cleaning and sterilization capabilities to deliver ready-to-use components to customers, expanding Freudenberg's contract manufacturing and design offerings in the single-use systems market.

Source · Medical Design & OutsourcingRead brief

§027New productsApril 20, 2026

How ZB’s Paragon 28 created a novel curved foot nail system

Zimmer Biomet's Paragon 28 division has launched a novel curved foot nail system designed to better match foot and ankle anatomy. The implant required development of three new instruments alongside the device itself. The innovation addresses surgical fixation for foot and ankle procedures.

Source · Medical Design & OutsourcingRead brief

§028New productsApril 17, 2026

The first year-long CGM implant developer isn’t done yet

Senseonics launched Eversense 365, the first implantable continuous glucose monitor (CGM) designed to function for a full year, in 2024. Unlike transcutaneous rivals from Abbott and Dexcom that use small needles to measure interstitial glucose, the Eversense system uses a different sensing approach. The company is advancing the implantable CGM category as a differentiated alternative in the glucose monitoring market.

Source · Medical Design & OutsourcingRead brief

§029TechnologyApril 16, 2026

Microstructure makes ePTFE a versatile medtech material

Expanded polytetrafluoroethylene (ePTFE) is a widely used material in medical devices with applications including vascular grafts and stent coatings. The material's versatility stems from its microstructure, which can be engineered in multiple forms to deliver varying properties such as chemical inertness, biocompatibility, flexibility, and durability. Understanding these structural variations is important for device engineers selecting ePTFE for specific applications.

Source · Medical Design & OutsourcingRead brief

§030MarketApril 15, 2026

Abbott’s device leader pay climbs again with double-digit sales growth

Abbott's EVP and Medical Devices Group President Lisa Earnhardt received a compensation package increase exceeding 20% in 2025, reflecting double-digit sales growth in the division. Abbott ranked eighth globally among medical device companies by revenue in the latest Medtech Big 100 rankings. The pay rise underscores strong financial performance in the device segment amid broader market momentum.

Source · Medical Design & OutsourcingRead brief

§031New productsApril 15, 2026

MiniMed flexes with next-gen insulin pump after spinning off from Medtronic

MiniMed, recently spun off from Medtronic via March IPO, secured FDA clearance for its next-generation MiniMed Flex automated insulin delivery system. The screenless, compact pump represents a product advancement for the standalone diabetes-device company and signals continued R&D investment in its core insulin-delivery portfolio following the separation from its former parent.

Source · Medical Design & OutsourcingRead brief

§032New productsApril 14, 2026

BMF launches clear resin for transparent micro 3D printing

Boston Micro Fabrication introduced BMF Clear resin, enabling optical transparency in micro-precision 3D printing. The material addresses manufacturing gaps for microfluidic devices and optical components, enabling applications such as direct printing of micro-lenses onto fiber optic tips and sensor surfaces. The resin expands scalable production options for previously difficult-to-manufacture medical device components.

Source · Medical Design & OutsourcingRead brief

§033MarketApril 13, 2026

Switchback Medical is expanding into Costa Rica

Switchback Medical, a medical device contract development and manufacturing organization, has signed a lease for an 18,000-square-foot facility in Costa Rica's Coyol Free Trade Zone. The expansion marks the company's first international manufacturing footprint outside its Brooklyn Park, Minnesota headquarters, signaling a strategic shift in production capacity and supply-chain positioning for the CDMO sector.

Source · Medical Design & OutsourcingRead brief

§034MarketApril 10, 2026

CDMO Arterex upgrades manufacturing facility near Boston

Arterex, a contract device manufacturer, is expanding its Mansfield, Massachusetts facility by 15,000 square feet and installing a new steam sterilizer to boost operational capacity by nearly 50%. The upgrade aims to improve inventory control and logistics efficiency for its contract manufacturing customers.

Source · Medical Design & OutsourcingRead brief

§035MarketApril 10, 2026

Medtech CDMO Integer discloses executive pay after new CEO steps in

Integer Holdings Corp., a contract manufacturer and CDMO for medical devices, disclosed executive compensation packages following a new CEO appointment in an SEC filing. The company also reported a significant increase in median employee pay. Integer ranks among the top 60 medical device companies globally.

Source · Medical Design & OutsourcingRead brief

§036MarketApril 1, 2026

Whoop raises $575M series G, Abbott comes on board amid hiring spree

Whoop, a fitness wearable maker, raised $575 million in Series G funding with Abbott as a new investor. The round comes as Whoop expands hiring and positions itself for growth in the consumer health monitoring space. Abbott's participation signals potential distribution or integration opportunities between the companies.

Source · Fierce HealthcareRead brief

§037TechnologyMarch 11, 2026

UPDATED: Stryker hit by international cyberattack linked to pro-Iran group

Stryker Corporation experienced a significant cyberattack attributed to a pro-Iran threat actor that resulted in data wiping across enterprise systems and disrupted employee access. The incident highlights vulnerabilities in medical device manufacturer IT infrastructure and raises questions about business continuity for a major surgical equipment and orthopedic devices supplier. Stryker supplies hospitals and surgical centers globally with imaging systems, surgical instruments, and hospital beds.

Source · Fierce HealthcareRead brief

§038TechnologyMarch 2, 2026

Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results

Quest Diagnostics launched an AI-powered chatbot built on Google technology to help patients interpret laboratory test results. The tool allows customers to query their findings and access health insights independently. The move represents a digital engagement strategy by a major clinical laboratory vendor to enhance patient-facing services and differentiate its lab services platform.

Source · Fierce HealthcareRead brief

§039New productsFebruary 4, 2026

Hims & Hers to sell Grail’s Galleri multi-cancer blood test via its digital health platform

Hims & Hers, a telehealth platform, has begun offering Grail's Galleri multi-cancer blood test through its digital health service. Galleri is a cell-free DNA screening test designed to detect multiple cancer types from a single blood draw. The partnership expands access to the test via Hims & Hers' existing patient base and distribution channels, marking a move by the telehealth vendor into cancer screening diagnostics.

Source · Fierce HealthcareRead brief

§040MarketDecember 17, 2025

Medline makes Nasdaq debut, raising $6.26B in year's largest IPO

Medline Industries completed its Nasdaq initial public offering, raising $6.26 billion in the largest IPO of 2024. The medical device and supply distributor, previously held by private equity, transitions to public ownership. The offering marks a significant milestone for one of the U.S.'s largest medical equipment and consumables vendors and signals investor appetite for established medical-supply businesses.

Source · Fierce HealthcareRead brief